| CUE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CUE shares outstanding history going back to 1/2/2018:
Also see: CUE Market Cap History CUE YTD Return |
As of 5/12/2026 Cue Biopharma has 4.05 million CUE shares outstanding. Investors often track the CUE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CUE share count trends over time, with 34 historical shares outstanding datapoints presented, dating back to 1/2/2018.

| CUE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CUE shares outstanding history going back to 1/2/2018:
Also see: CUE Market Cap History CUE YTD Return |
| CUE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CUE Historical Shares Outstanding: +24.48% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CUE Stock Price Chart |
| About Cue Biopharma Inc |
| Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. Co.'s platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation. We show 34 historical shares outstanding datapoints in our coverage of CUE's shares outstanding history. Understanding the changing numbers of CUE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CUE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CUE by allowing them to research CUE shares outstanding history as well as any other stock in our coverage universe. |
| CUE Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| CUE Share Performance |
| Shares Outstanding Peers |
| Cue Biopharma (CUE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CUR Shares Outstanding History CUTR Shares Outstanding History CVKD Shares Outstanding History CVRX Shares Outstanding History CVS Shares Outstanding History CWBR Shares Outstanding History CYCC Shares Outstanding History CYCN Shares Outstanding History CYH Shares Outstanding History CYPH Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.